GSK Buys Back Own Shares

TL;DR

GSK is buying back its own stock via BNP Paribas.

AI Summary

GSK plc announced on November 14, 2025, that it purchased a certain number of its own ordinary shares of 31 1/4 pence each, acting through its broker, BNP Paribas SA. The filing does not specify the exact number of shares or the total dollar amount involved in these transactions.

Why It Matters

Share buybacks can signal management's confidence in the company's valuation and potentially increase earnings per share.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of share repurchases and does not contain significant new risks.

Key Players & Entities

• GSK plc (company) — Company making the share repurchase
• BNP Paribas SA (company) — Broker executing the share repurchase on behalf of GSK
• 31 1/4 pence (dollar_amount) — Nominal value of GSK's ordinary shares

FAQ

Filing Documents

• a4995h.htm (6-K) — 1896KB
• 0001654954-25-013014.txt ( ) — 1897KB

From the Filing

IN OWN SHARES a4995h   UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Form 6-K   REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934       For the month of November 2025   Commission File Number 001-15170     GSK plc (Translation of registrant's name into English)     79 New Oxford Street, London, WC1A 1DG (Address of principal executive office)       Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.   Form 20-F . . . .X. . . . Form 40-F . . . . . . . .       Transaction in own shares   GSK plc (the " Company ") announces today   acting through BNP Paribas SA (the " Broker "), it has purchased the following number of the Company's ordinary shares of  31¼  pence each.   Date of purchase: 13 November 2025 Aggregate number of ordinary shares of  31¼  pence each purchased: 167,000 Lowest price paid per share (GBp): 1,794.50p Highest price paid per share (GBp): 1,817.50p Volume-weighted average price paid per share (GBp): 1,806.51p   The purchased shares will be held   as Treasury shares.                                                                                                                            Such purchase forms part of the Company's existing buyback programme and was effected pursuant to the non-discretionary agreement entered into with the Broker, as announced on 30 September 2025. Since 30 September 2025, the Company has purchased 8,830,000 ordinary shares.   Following the above purchase, the Company will hold 256,294,844 ordinary shares in treasury and have 4,059,133,530 ordinary shares in issue (excluding Treasury shares).   The total number of voting rights in the Company is   4,059,133,530. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.   The Company confirms that, in accordance with DTR 5.5.1R, following the above purchase the percentage of voting rights attributable to the ordinary shares held in treasury is 6.31 per cent.   The table below contains detailed information of the individual trades made by the Broker on the London Stock Exchange and the CBOE Europe Limited recognised investment exchange (through its order books having market identification codes CHIX or BATE) as part of the buyback programme.     Schedule of Purchases Shares purchased:    GSK plc (ISIN: GB00BN7SWP63) Date of purchases:     13 November 2025 Investment firm:       BNP Paribas SA     Aggregated information per trading venue: Venue   Number of ordinary shares purchased   Highest price paid (per ordinary share)(GBp)   Lowest price paid (per ordinary share)(GBp)   Volume weighted average price paid (per ordinary share) (GBp)   BATE   22,898   1,815.50p   1,795.50p   1,806.59p   CHIX   55,309   1,815.50p   1,795.00p   1,806.93p   XLON   88,793   1,817.50p   1,794.50p   1,806.22p       Individual transactions: Number of Shares   Price per Share (GBp)   Trading venue   Date of transaction   Time of transaction   Transaction reference number   206   1811.5   XLON   13-Nov-2025   08:01:19   20251113153080392   68   1811.5   XLON   13-Nov-2025   08:01:19   20251113153080394   176   1811.5   CHIX   13-Nov-2025   08:01:19   20251113153080396   206   1810.0   CHIX   13-Nov-2025   08:02:06   20251113153081025   18

View Full Filing

View this 6-K filing on SEC EDGAR